References
- Billington EO, Phang SH, Gregson DB, et al. Incidence, risk factors, and outcomes for Enterococcus spp. blood stream infections: a population-based study. Int J Infect Dis. 2014;26:76–82.
- Pinholt M, Ostergaard C, Arpi M, et al. Incidence, clinical characteristics and 30-day mortality of enterococcal bacteraemia in Denmark 2006–2009: a population-based cohort study. Clin Microbiol Infect. 2014;20(2):145–151.
- Weiner LM, Webb AK, Limbago B, et al. Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2011–2014. Infect Control Hosp Epidemiol. 2016;37(11):1288–1301.
- Ostergaard L, Bruun NE, Voldstedlund M, et al. Prevalence of infective endocarditis in patients with positive blood cultures: a Danish Nationwide Study. Eur Heart J. 2019;40(39):3237–3244.
- Kreidl P, Kirchner T, Fille M, et al. Antibiotic resistance of blood cultures in regional and tertiary hospital settings of Tyrol, Austria (2006–2015). PLoS One. 2019;14(10):e0223467.
- DiazGranados CA, Zimmer SM, Klein M, et al. Comparison of mortality associated with vancomycin-resistant and vancomycin-susceptible enterococcal bloodstream infections: a meta-analysis. Clin Infect Dis. 2005;41(3):327–333.
- Laupland KB. Defining the epidemiology of bloodstream infections: the 'gold standard' of population-based assessment. Epidemiol Infect. 2013;141(10):2149–2157.
- Al-Hasan MN, Eckel-Passow JE, Baddour LM. Influence of referral bias on the clinical characteristics of patients with Gram-negative bloodstream infection. Epidemiol Infect. 2011;139(11):1750–1756.
- Laupland KB, Pasquill K, Dagasso G, et al. Population-based risk factors for community-onset bloodstream infections. Eur J Clin Microbiol Infect Dis. 2019;39(4):753–758.
- Laupland KB, Pasquill K, Parfitt EC, et al. Burden of community-onset bloodstream infections, Western Interior, British Columbia, Canada. Epidemiol Infect. 2016;144(11):2440–2446.
- CLSI. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard – tenth edition. Wayne (PA): Clinical and Laboratory Standards Institute; 2015.
- Friedman ND, Kaye KS, Stout JE, et al. Health care-associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann Intern Med. 2002;137(10):791–797.
- Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–383.
- Population Estimates, BCstats; 2019; [cited 2019 Mar 27]. Available from: http://www.bcstats.gov.bc.ca/StatisticsBySubject/Demography/PopulationEstimates.aspx
- Population/Local Health Areas & Facility Profiles; 2019. Available from: https://www.interiorhealth.ca/AboutUs/QuickFacts/PopulationLocalAreaProfiles/Pages/default.aspxv; [cited 2019 Apr 22].
- HIV Monitoring Quarterly Report: interior health; 2019; [cited 2019 Apr 22]. Available from: http://stophivaids.ca/qmr/2018-Q4/#/iha
- Ellison LF, Wilkins K. Canadian trends in cancer prevalence. Health Rep. 2012;23(1):7–16.
- Prevalence of Chronic Diseases Among Canadian Adults, Public Health Agency of Canada; 2019; [cited 2019 Apr 22]. Available from: https://www.canada.ca/en/public-health/services/chronic-diseases/prevalence-canadian-adults-infographic-2019.html
- Heart Disease in BC, Cardiac Services BC; 2019; [cited 2019 Apr 22]. Available from: http://www.cardiacbc.ca/health-info/heart-disease-in-bc
- Stroke in Canada: Highlights from the Canadian Chronic Disease Surveillance System, Public Health Agency of Canada; 2019; [cited 2019 Apr 22]. Available from: https://www.canada.ca/en/public-health/services/publications/diseases-conditions/stroke-canada-fact-sheet.html
- Arora P, Vasa P, Brenner D, et al. Prevalence estimates of chronic kidney disease in Canada: results of a nationally representative survey. CMAJ. 2013;185(9):E417–E423.
- Liver Disease in Canada, Canadian Liver Foundation; 2019; [cited 2019 Apr 23]. Available from: https://www.liver.ca/wp-content/uploads/2017/09/Liver-Disease-in-Canada-E-3.pdf
- Lovell M, Harris K, Forbes T, et al. Peripheral arterial disease: lack of awareness in Canada. Can J Cardiol. 2009;25(1):39–45.
- Wong R, Davis AM, Badley E, et al. Prevalence of arthritis and rheumatic diseases around the world; 2010. MOCA; [cited 2019 Apr 22]. Available from: http://www.modelsofcare.ca/pdf/10-02.pdf
- Maki DG, Agger WA. Enterococcal bacteremia: clinical features, the risk of endocarditis, and management. Medicine (Baltimore). 1988;67(4):248–269.
- Huysman E, Mathieu C. Diabetes and peripheral vascular disease. Acta Chir Belg. 2009;109(5):587–594.
- Schonwald S, Begovac J, Skerk V. Urinary tract infections in HIV disease. Int J Antimicrob Agents. 1999;11(3–4):309–311.
- Salgado CD, Farr BM. Outcomes associated with vancomycin-resistant enterococci: a meta-analysis. Infect Control Hosp Epidemiol. 2003;24(9):690–698.
- Noskin GA, Peterson LR, Warren JR. Enterococcus faecium and Enterococcus faecalis bacteremia: acquisition and outcome. Clin Infect Dis. 1995;20(2):296–301.
- Laupland KB, Niven DJ, Pasquill K, et al. Culturing rate and the surveillance of bloodstream infections: a population-based assessment. Clin Microbiol Infect. 2018;24(8):910e1–e4.